Peroxisomal proliferator-activated receptor-γ upregulates glucokinase gene expression in β-cells

Diabetes

Volumn 51, Issue 3, 2002, Pages 676-685

  Kim, Ha Il ^a   Cha, Ji Young ^a   Kim, So Youn ^a   Kim, Jae Woo ^a   Roh, Kyung Jin ^a   Seong, Je Kyung ^a   Lee, Nam Taek ^b   Choi, Kang Yell ^a   Kim, Kyung Sup ^a   Ahn, Yong Ho ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea Military Academy   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; RETINOID X RECEPTOR; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GLUCOSE HOMEOSTASIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; RAT;

EID: 0036310015     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.3.676     Document Type: Article

References (36)

1. Glucose sensing in pancreatic β-cells
2. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion
3. Glucose-induced toxicity in insulin-producing pituitary cells that coexpress GLUT2 and glucokinase: Implication for metabolic engineering
4. Pancreatic islet glucose metabolism and regulation of insulin secretion
5. Molecular pathogenesis of MODYs
6. Characterization of new oral antidiabetic agent CS-045: Studies in KK and ob/ob mice and Zucker fatty rats
7. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone
8. Treatment with oral antidiabetic agent troglitazone improves β-cell responses to glucose in subjects with impaired glucose tolerance
9. Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone
10. Peroxisome proliferator-activated receptor γ and metabolic disease
11. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension
12. PPARγ adipogenic regulator and thiazolidinedione receptor
13. Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats
14. Troglitazone lowers islet fat and restores beta cell function of Zucker diabetic fatty rats
15. Identification and functional characterization of the peroxisomal proliferator reponse element in rat GLUT 2 promoter
16. Unraveling the mechanism of action of thiazolidinediones
17. An alternate promoter in the glucokinase gene is active in the pancreatic cell
18. Rat glucokinase gene: Structure and regulation by insulin
19. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines
20. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms
21. Novel sequence determinants in peroxisomal proliferator signaling
22. Glucokinase
23. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
24. Glucokinase gene structure: Functional implications of molecular genetic studies
25. Expression of normal and novel glucokinase mRNAs in anterior pituitary and islet cells
26. Human glucokinase gene: Isolation, structural characterization, and identification of a microsatellite repeat polymorphism
27. Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture
28. Multiple elements in the upstream glucokinase promoter contribute to transcription in insulinoma cells
29. The human glucokinase gene beta-cell-type promoter: An essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T 15 cells
30. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus
31. Cyclic adenosine 3′,5′-monophosphate increases pancreatic glucokinase activity and gene expression
32. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression
33. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells
34. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: Prospective studies of Pima Indians
35. The triumvirate B-cell, muscle, liver: A collusion responsible for NIDDM
36. Glucose affects in vitro maturation of fetal rat islets